CA 19-9 Test

If you or a family member has been advised to take a CA 19-9 test, you may wonder whether it can detect cancer early. The honest answer is no. CA 19-9 is a tumor marker – a substance that can be measured in blood – but it is not a screening test for cancer. Its main role is to help doctors monitor treatment response and watch for recurrence in patients who already have pancreatic cancer. It can also be elevated in several non-cancerous conditions, so the result must always be interpreted by a qualified clinician in the context of other tests and imaging.

What Is the CA 19-9 Test?

CA 19-9 stands for carbohydrate antigen 19-9, a type of sialyl Lewis a antigen that is often found on the surface of certain cancer cells. The test measures the amount of this antigen in your blood. While it is most commonly associated with pancreatic cancer, elevated levels can also occur in cancers of the bile duct, stomach, or colon. Importantly, CA 19-9 is not a direct cancer test – it is a tumor marker, meaning its levels can go up for reasons other than malignancy.

Primary Use: Monitoring Pancreatic Cancer Treatment

The greatest value of the CA 19-9 test lies in monitoring patients already diagnosed with pancreatic cancer. After surgery, chemotherapy, or radiation, doctors track CA 19-9 levels to see if the treatment is working. A falling level usually suggests a good response, while a rising level may indicate that the cancer is growing or that a recurrence is happening. It is not used to find cancer in people without symptoms or to screen the general population.

Limitations: False Positives and False Negatives

CA 19-9 has two important limitations that every patient should know:

• False positives: Benign conditions such as pancreatitis, cholangitis, gallstones, bile duct obstruction, and even severe jaundice can raise CA 19-9 levels. This means a high result does not automatically mean cancer.
• False negatives: About 10% of the population (people who lack the Lewis blood group antigen) cannot produce CA 19-9 at all. In these individuals, the test will always be low even if cancer is present. Additionally, early-stage pancreatic cancer often has normal CA 19-9 levels.

Because of these limitations, a single CA 19-9 result should never be used alone to diagnose or rule out cancer.

Normal Range and What Elevated Levels Mean

The reference range for CA 19-9 varies slightly between laboratories, but a level below 37 U/mL is generally considered normal. Here is a rough guide to interpretation:

Level (U/mL)	Interpretation
<37	Normal – but does not rule out early cancer
37–100	Mild elevation – may be benign; needs repeat testing and clinical correlation
>100	More concerning – warrants imaging (CT, MRI) and further investigation

Levels above 100 U/mL raise suspicion, but even very high values can be caused by benign biliary obstruction. Only a doctor can interpret your result in combination with your symptoms, physical exam, and imaging findings.

When Does a Doctor Order This Test?

A doctor may order a CA 19-9 test in the following situations:

• After a pancreatic cancer diagnosis – to monitor treatment response or detect recurrence.
• When symptoms like jaundice, unexplained weight loss, or abdominal pain persist – but only after other tests (imaging, biopsy) suggest a possible malignancy.
• Rarely, as part of a preoperative evaluation for suspected bile duct or pancreatic tumors.

It is not a first-line diagnostic tool. Do not request this test on your own out of fear of cancer. Always discuss with a gastroenterologist or oncologist first.

Cost of CA 19-9 Test in Bangladesh

The price of the CA 19-9 test varies depending on the city, laboratory accreditation, and whether it is done as a single test or as part of a tumor marker panel. Below are typical private-lab and hospital ranges in Bangladesh. Prices change frequently; always confirm with the laboratory before testing.

Approximate Cost of CA 19-9 Test in Bangladesh (Private Labs & Hospitals)

Item	Approx. BDT Range	Notes
CA 19-9 (single test)	800 – 1,500	Commonly 1,000–1,200 in Dhaka; may be higher in super-specialty hospitals
Tumor marker panel (e.g., CEA + CA 19-9 + AFP)	2,500 – 4,000	Cheaper per marker than individual tests
Home collection / urgent service	+200 – 500 extra	Availability depends on lab

Larger chains such as Popular, Ibn Sina, Medinova, and hospitals like Square, Apollo (Evercare), or LabAid offer this test. Prices outside Dhaka may be slightly lower, but the range above covers most of Bangladesh.

Find Doctors by Division in Bangladesh

If your doctor has recommended a CA 19-9 test and you need a specialist for follow-up, you can find qualified general surgeons and laparoscopic surgeons across Bangladesh using the directory below. These doctors are trained to evaluate pancreatic and biliary conditions.

Division	Find a doctor
Dhaka / ঢাকা	General Surgeon doctors in Dhaka
Dhaka / ঢাকা	Laparoscopic Surgeons in Dhaka
Chattogram / চট্টগ্রাম	Top General Surgeon Doctors in Chattogram
Chattogram / চট্টগ্রাম	Verified Laparoscopic Surgeon Doctors in Chattogram
Khulna / খুলনা	Popular General Surgeon Doctors in Khulna
Khulna / খুলনা	Recommended Laparoscopic Surgeon Doctors in Khulna
Rajshahi / রাজশাহী	General Surgeon Specialists in Rajshahi
Rajshahi / রাজশাহী	Find Laparoscopic Surgeons in Rajshahi
Rangpur / রংপুর	General Surgeons in Rangpur
Rangpur / রংপুর	Popular Laparoscopic Surgeon Doctors in Rangpur
Sylhet / সিলেট	Best General Surgeon Doctors in Sylhet
Sylhet / সিলেট	Popular Laparoscopic Surgeon Doctors in Sylhet
Barishal / বরিশাল	Barishal General Surgeon Doctors
Barishal / বরিশাল	Laparoscopic Surgeon Doctors in Barishal
Mymensingh / ময়মনসিংহ	Popular General Surgeon Doctors in Mymensingh

Key Takeaways

• CA 19-9 is a tumor marker used for monitoring pancreatic cancer, not for early diagnosis or screening.
• Elevated levels can result from benign conditions (pancreatitis, jaundice) and about 10% of people cannot produce the marker at all.
• Always consult a doctor for interpretation; never self-refer based on fear of cancer.
• The test costs around 800–1,500 BDT in Bangladesh; prices vary by lab and city.
• If you need a specialist, use the directory above to find a qualified surgeon near you.

Frequently Asked Questions

Can the CA 19-9 test be used to screen for pancreatic cancer in people without symptoms?

No. The CA 19-9 test is not a screening tool for the general population. It has low sensitivity and specificity for early-stage disease, meaning it can miss many cancers and also produce false-positive results due to benign conditions. Screening for pancreatic cancer is not currently recommended for asymptomatic individuals.

What non-cancerous conditions can cause a high CA 19-9 level?

Several benign conditions can elevate CA 19-9, including pancreatitis (acute or chronic), gallstones, cholangitis, hepatitis, cirrhosis, and even benign biliary obstruction or jaundice. Even simple ovarian cysts or endometriosis may occasionally cause a mild rise. That is why an elevated result must always be interpreted alongside imaging and clinical findings.

How often is the CA 19-9 test repeated during pancreatic cancer treatment?

The frequency is determined by the treating oncologist based on the treatment plan. Typically, it is measured before starting a new treatment cycle (e.g., chemotherapy) and then again after a few cycles to assess response. After surgery, it may be checked every few months to monitor for recurrence. The exact schedule varies per patient.

If my CA 19-9 level is normal, does that mean I absolutely do not have pancreatic cancer?

No. A normal CA 19-9 level does not rule out pancreatic cancer. Some pancreatic tumors do not produce this marker (false-negative result), especially in early stages or in certain tumor types. Imaging studies such as CT or MRI remain essential for diagnosis. Your doctor will never rely solely on a normal CA 19-9 to exclude cancer.

Is the CA 19-9 test widely available in Bangladesh, and is it covered by insurance?

The test is available in major diagnostic centres in Dhaka, Chittagong, Rajshahi, Khulna, and Sylhet, as well as in many district-level hospitals with pathology labs. Health insurance plans in Bangladesh often cover tumor marker tests if ordered by a registered specialist, but you should confirm with your insurer beforehand. Costs typically range from 500 to 1,500 BDT depending on the facility.

Sources

The following sources are from international journals, government health agencies, or recognized medical organizations:

• CA 19-9 in Pancreatic Cancer: A Brief Overview (ncbi.nlm.nih.gov)
• CA 19-9 Test: What It Is and Why It’s Done (mayoclinic.org)
• Pancreatic Cancer: Early Detection and Screening (nice.org.uk)
• World Health Organization — CA 19-9 Test (who.int)
• MedlinePlus — CA 19-9 Test (medlineplus.gov)
• CDC — CA 19-9 Test (cdc.gov)